Back to search
FDAFDA · Food and drugs·Recall number D-0260-2024

Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India. Distributed by:Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-752-16

Published January 31, 2024 · Recall initiated: December 29, 2023

Summary

FDA records drug Class II recall D-0260-2024, published January 31, 2024 and initiated December 29, 2023. Recalling firm: Strides Pharma Inc.; Status: Terminated; Reported quantity: 396 50-count bottles; Lot: Lot #: 7253092B, Exp Date 09/30/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if METHOXSALEN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METHOXSALEN
Manufacturer
Strides Pharma Inc.
Distributor
Nationwide in the USA
UPC
0364380752165
Lot
Lot #: 7253092B, Exp Date 09/30/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India. Distributed by:Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-752-16 recalled?

Yes. FDA published recall D-0260-2024 on January 31, 2024. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METHOXSALEN. UPC: 0364380752165.